In the current session, the stock is trading at $118.67, after a 2.26% increase. Over the past month, Abbott Laboratories Inc. (NYSE:ABT) stock increased by 3.30%, and in the past year, by 24.34%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.
Comparing Abbott Laboratories P/E Against Its Peers
The P/E ratio is used by long-term shareholders to assess the company's ...